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Symbiotic relationships between neurons and glia must adapt to
structures, functions, and metabolic roles of the tissues they are
in. We show here that Müller glia in retinas have specific enzyme
deficiencies that can enhance their ability to synthesize Gln. The
metabolic cost of these deficiencies is that they impair the Müller
cell’s ability to metabolize Glc. We show here that the cells can
compensate for this deficiency by using metabolites produced by
neurons. Müller glia are deficient for pyruvate kinase (PK) and
for aspartate/glutamate carrier 1 (AGC1), a key component of the
malate-aspartate shuttle. In contrast, photoreceptor neurons ex-
press AGC1 and the M2 isoform of pyruvate kinase, which is
commonly associated with aerobic glycolysis in tumors, prolifer-
ating cells, and some other cell types. Our findings reveal a pre-
viously unidentified type of metabolic relationship between
neurons and glia. Müller glia compensate for their unique meta-
bolic adaptations by using lactate and aspartate from neurons as
surrogates for their missing PK and AGC1.
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Aerobic glycolysis is a metabolic adaptation that proliferatingcells use to meet anabolic demands (1, 2). In tumors, it is
called the “Warburg effect.” Tumors convert ∼90% of Glc they
consume to lactate (Lac). The brain converts only 2–25% of the
Glc it uses to Lac (3).
In retinas of vertebrate animals, energy is produced in a way
that resembles tumor metabolism more than brain metabolism.
Aerobic glycolysis accounts for 80–96% of Glc used by retinas
(4–7). Retinas are made up of neurons and glia (8). The out-
ermost layer is occupied by photoreceptors (PRs). The inner
layers are a diverse collection of signal processing neurons.
Müller glia spans the thickness of the retina. The site of aerobic
glycolysis in retina has not been established.
Exchange of fuels is an important part of the relationship be-
tween neurons and glia (9–12). Transfer of metabolites between
intracellular compartments also is important. Glycolysis is sup-
ported by reoxidation of cytosolic NADH, which can be catalyzed
by lactate dehydrogenase (LDH) or by the malate-aspartate
shuttle (MAS). PRs and other neurons in retinas express aspar-
tate/glutamate carrier 1 (AGC1; also known as “Aralar”) (13),
a mitochondrial aspartate/glutamate carrier that has a key role in
the MAS. However, Müller cells (MCs) are AGC1-deficient (13).
The significance of the distribution of AGC1 has been enigmatic.
Aerobic metabolism in tumors is linked to expression of the
M2 isoform of pyruvate kinase, PKM2 (14, 15). Pyruvate kinase
(PK) catalyzes the final step in glycolysis, synthesis of Pyr (16).
Liver (PKL) and erythrocyte (PKR) isoforms are splice variants
of the PKLR gene, and PKM1 and PKM2 are splice variants of
the PKM gene. A unique feature of PKM2 is that it is responsive
to allosteric and posttranslational regulators (16). PKM2 ex-
pression in cancer cells correlates with reduced yield of ATP
from Glc and accumulation of glycolytic intermediates. PKM2
also favors synthesis of Ser and pentose phosphate pathway
intermediates that support anabolic activity (17).
Association of PKM2 with aerobic glycolysis in tumors moti-
vated us to explore the relationship between PKM2 and aerobic
glycolysis in retina. We found that PKM2 is abundant and only in
the outer retina, implicating PRs as a primary site of aerobic
glycolysis. Unexpectedly, we also found MCs are deficient for all
isoforms of PK.
The deficiency of MCs for AGC1 and PK led us to investigate
metabolic relationships between PRs and MCs. We found cul-
tured MCs have an impaired ability to metabolize Glc, but they
metabolize Asp effectively. Our findings reveal that metabolic
benefits of down-regulating PK and AGC1 in MCs have led to
specific metabolic adaptations in the retina. Rather than use Glc
to fuel their mitochondria, MCs use Lac and Asp from neurons
as surrogates for their missing PK and AGC1 activities.
Results
Glycolytic Enzyme Activities in Mouse Retinas. We compared max-
imum specific activities of glycolytic enzymes in homogenates of
retina, muscle, brain, liver, a transformed MC line (RMC-1)
(18), and HeLa cells. These values represent maximum possible
activity for each enzyme, and not the activity it would have in the
cell. The activities generally increase from the first step to the
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final step of glycolysis. PK has the highest activity in all tissues
except liver (Fig. 1A).
PKM2 Is Abundant in Retina.We evaluated PK expression in brain,
liver, muscle, and retina with antibodies specific for PKLR,
PKM1, and PKM2. PKLR is in homogenates of liver but not
retina (Fig. 1B). Consistent with this finding, no PKLR was
found in a proteomic analysis of rat retina (19). PKM1 is in
brain, muscle, and retina, whereas PKM2 is most abundant in
retina (Fig. 1B). We quantified PKM1 and PKM2 in mouse
retina by calibration with pure recombinant PKM1 and PKM2
(concentration determined by amino acid analysis) (Fig. 1C).
Our analysis showed there are ∼150 pmol of PKM2 and
∼26 pmol of PKM1 per mouse retina. PKM2 is present at 25%
of the amount of rhodopsin, the most abundant protein in PRs
(∼600 pmol per retina) (20, 21).
PKM2 Is Only in PRs. We evaluated the distribution of PK in light-
adapted retinas by assaying PK activity in serial sections of frozen
unfixed rat retinas (22, 23) (Fig. 2A). We noted two distinct
peaks of activity. Rhodopsin and synaptotagmin marked outer
segments and synaptic terminals of PRs. Immunoblot analysis
(Fig. 2A, Top) detected PKM2 only in the outer retina. Immu-
nohistochemical analysis showed that PKM2 is confined to cell
bodies and synaptic terminals of PRs (Fig. 2B, Left), whereas
PKM1 is in PRs and inner retinal neurons (Fig. 2C, Left).
PKM2 Is Regulated Allosterically but Not Influenced, by Light. PKM2
is sensitive to multiple types of regulation (16). We found that
Phe (5 mM) inhibits PK activity in retinal homogenates. Fructose
1,6-bisphosphate (1 mM) stimulates it by 15% and is effective at
reversing inhibition of PK activity caused by Phe (Fig. S1). We
were unable to find differences between PK activity in homog-
enates prepared from light vs. dark-adapted retinas. Immuno-
blotting did not reveal any light vs. dark effects on Y105
phosphorylation (24) or on PKM1 or PKM2 expression.
PKM2 in cancer cells diverts glycolytic intermediates to Ser
and Gly synthesis (25). We incubated retinas with U-13C Glc and
compared incorporation of 13C into Lac vs. into Ser. In 5 min,
44 ± 2% of 12C Lac is replaced by 13C Lac in light vs. 52 ± 5% in
darkness. In some cancer cells, labeling of Ser from 13C Glc is
detected within 10 min (17). We found no labeling of Ser from
13C Glc in retinas even after 6 h. PKM2 in retina does not divert
carbons from glycolysis into Ser to the extent it does in cancer
cells. PKM2 is excluded from nuclei in retinas, so it also is un-
likely to influence transcription (16).
MCs Are Deficient for All PK Isoforms. We evaluated PKM1 and
PKM2 in MCs in retinas by colabeling retinas with an MC-specific
marker, cellular retinaldehyde binding protein (CRALBP) (Fig. 2
B and C,Middle). Neither colocalized with CRALBP (Fig. 2 B and
C, Right). To confirm our method detects glycolytic proteins in
MCs, we also probed CRALBP-labeled sections with antibodies to
enolase and GAPDH. Both colocalize with CRALBP (Fig. S2).
We also mined a published gene expression database derived
fromMCs isolated from mouse retinas (26). To evaluate how well
this database reflects native MC expression, we examined genes
expressed only in PRs (GNAT1 and IRBP) or only in MCs
[glutamine synthetase (GLUL) and CRALBP]. Our analysis con-
firmed the accuracy of the database. GNAT1 and IRBP occur
more frequently in PRs than in MCs, and GLUL and CRALBP
occur more frequently in MCs than in PRs (Fig. S3). We also
analyzed PKM and PKLR. PKM sequences are enriched in PRs,
whereas they are 12-fold less abundant in MCs. PKLR is 50- to
100-fold less abundant than PKM in both PRs and MCs (Fig. S3).
Lac Production in Retina.Our findings that MCs do not express PK
and that PRs express abundant PKM2 suggested that PRs, and
not MCs, are the primary source of Lac. Retinas convert Glc to
Lac at a very fast rate (4–7, 13). To determine if PRs are the
major source of Lac, we compared retinas with PRs and retinas
without PRs. Adult aryl hydrocarbon interacting protein-like
1 (AIPL1− /−) mouse retinas have no PRs because AIPL1
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Fig. 1. Glycolytic enzymes in retina. (A) Activities of glycolytic enzymes in
homogenates of retina, muscle, liver, and brain. Activities were measured at
substrate concentrations above the reported Km for each enzyme. (B) Im-
munoblot analysis of PK isoforms in homogenates of whole brain, liver,
muscle, and retina. DA, dark-adapted; LA, light-adapted. GNAT1−/− retinas
were included because they are unresponsive to light. rMC-1 is an SV-40
transformed MC line (18), and HeLa is a cancer cell line. The blot is repre-
sentative of two experiments. Each lane is loaded with 5 μg of protein. (C)
Quantitative immunoblot analysis comparing retina homogenate with known
amounts of purified PKM1 and PKM2.
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Fig. 2. Distribution of PK in retina. (A, Top) Distribution of PK activity in
serial sections of rat retina. (A, Middle) Rhodopsin shows the location of PR
outer segments. (A, Bottom) Synaptotagmin shows locations of synapses.
Immunoblot shows PKM2 immunoreactivity. (B) Immunohistological locali-
zation of PKM2 (Left), CRALBP (Middle), and their overlap (Right) in mouse
retina. (C) Immunohistological localization of PKM1 (Left), CRALBP (Middle),
and their overlap (Right) in mouse retina.
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deficiency causes PR degeneration (27), so we extracted me-
tabolites from mutant and control retinas and quantified them by
GC/MS (Fig. S4). Taurine and docosahexaenoic acid, which are
PR-specific metabolites, are reduced 90% and 83% in AIPL1−/−
retinas. Lac is also decreased by 74%, consistent with PRs being
the major site of Lac production. Gln accumulates, indicating
PRs are a major site for Gln degradation.
Cultured MCs Are Less Effective Than Intact Retinas at Converting Glc
to Lac. To evaluate contributions of MCs to Lac production, we
used MCs isolated from young mouse retinas and cultured for 10–
14 d. During that time, MCs grow to confluence, whereas neurons
degenerate (28). We incubated cultured MCs with 13C Glc and
used GC/MS to measure the appearance of M3 isotopomers of Lac
and Pyr (Fig. 3A). The time course of incorporation of 13C fromGlc
into whole-mouse retina metabolites is shown for comparison. The
13C from Glc is incorporated into Lac ∼60-fold faster in whole
retinas than in cultured MCs. This finding indicates neurons, and
not MCs, are the primary site of Lac synthesis in retinas.
Asp Is the Preferred Fuel for Cultured MCs. To quantify fuel prefer-
ences of cultured MCs, we incubated them for 1 h with either U-13C
Lac or U-13C Glc and measured incorporation of 13C into tri-
carboxylic acid cycle (TCA) intermediates (Fig. 3 B and C). Neither
Lac nor Glc contributed much 13C (Fig. 3 B and C). We also tested
U-13C Asp because Pardo et al. (29) found that other types of glial
cells use Asp. We found Asp is the fuel used most effectively by
cultured MCs to contribute carbons to TCA intermediates (Fig.
3D). An isotopomer analysis (Fig. S5) shows how cultured MCs
convert U-13C Asp into citrate, α-ketoglutarate, Glu, and Gln. MCs
also use carbons from Asp to make malate and fumarate by reverse
malate dehydrogenase and fumarase reactions. The cells label very
little succinate. Rapid exchange of cytosolic malate for mitochon-
drial α-ketoglutarate limits the extent to which intermediates are
recycled through the TCA cycle.
Asp Enhances Glycolysis in Cultured MCs. We reasoned that Asp
might stimulate oxidation of Glc by enhancing regeneration of
cytosolic NAD+. Asp entering MCs can be transaminated to
oxaloacetate, which then oxidizes NADH. We tested this rea-
soning by incubating cultured MCs with U-13C Glc with vs.
without Asp, and found Asp enhances incorporation of 13C into
Pyr and Lac (Fig. 4A).
Asp Enhances Incorporation of Carbons from Glc and Lac into
Mitochondrial Intermediates. Asp also enhances incorporation in-
to citrate of two 13Cs from either U-13C Glc or U-13C Lac (Fig. 4B).
We also noted evidence of Pyr carboxylase activity. In the pres-
ence of U-13C Glc or U-13C Lac, ∼10% of malate and citrate in
retina incorporates three 13Cs (Fig. 4C). The M3 isotopomers are
formed when M3 Pyr is incorporated into mitochondrial inter-
mediates by Pyr carboxylase. The contribution of Pyr carboxylase
becomes minor when unlabeled Asp is present (Fig. 4C).
Asp and Lac Enhance Gln Synthesis in Cultured MCs and in Retina.
MCs can synthesize Gln. However, when we use Glc as the only
fuel, neither cultured MCs (Fig. 4D) nor intact retinas (7) re-
leased much Gln into the culture medium. We found sixfold
more Gln in the medium when Glc is supplemented with Asp.
When Asp is provided with Lac instead of Glc, Gln rose 42-fold
compared with Glc alone (Fig. 4D).
To confirm that MCs use Lac and Asp in a more physiological
context, we incubated whole intact retinas with 13C Lac for 2 h with
vs. without Asp. We measured Gln in the retinas instead of in the
medium because Gln release is undetectable from light-adapted
retinas (7). Asp caused a 144-fold increase in labeling of Gln, which
is made only in MCs (Fig. 4E). Labeling of TCA intermediates,
which occurs in all retinal cells, was stimulated only 1.5-fold to
sevenfold by Asp (right side of Fig. 4E). We also incubated retinas
with 5 mM Lac, together with 5 mMAsp, dimethyl α-ketoglutarate,
dimethyl succinate, dimethyl fumarate, Asn, or Pro. Asp and Asn
were the most effective at raising levels of Gln (Fig. 4F).
MCs Lack Biochemical Pathways Needed to Sustain Glycolysis. Nei-
ther 13C Glc alone nor 13C Lac alone is an effective source of
carbon for mitochondrial intermediates (Fig. 3 B and C). The
limited ability of cultured MCs to incorporate 13C from Glc or
Lac could mean they cannot make cytosolic NAD+ fast enough
to sustain oxidation of these fuels.
To sustain glycolysis, a cell must reoxidize NADH. LDH can
regenerate NAD+ by converting Pyr to Lac. However, MCs are
PK-deficient, so they cannot make enough Pyr to support this
conversion. MAS activity would be an alternative way to re-
generate NAD+ (30), but AGC1, a key component of the MAS,
is absent from MCs in retinas (13) (Fig. S2). Consistent with this
localization data, microarray data revealed low AGC1 expression
in MCs (0.031% of total transcripts in PRs vs. 0.0003% in MCs)
(26). The glycerol-3-phosphate shuttle (30) is unlikely to play
a major role because transcripts encoding the two glycerol-3-
phosphate dehydrogenases are of low abundance in both PRs and
MCs (each is ∼0.0006% of total transcripts) (26).
Caveats Associated with Cultured MCs. The experiments we have
described so far were done mostly with MCs dissociated from
p12 retinas and cultured for 10–14 d. MCs under these con-
ditions partially dedifferentiate (28). They retain some native
characteristics but lose others.
We evaluated how much dedifferentiation occurs in our cul-
tured MCs. The MC-specific proteins CRALBP and glutamine
synthetase (GS) are present (Fig. S6), but only at 65 ± 5% and
8 ± 4% of levels in whole retina. AGC1 is present at 37 ± 5% and
PKM2 is present at 39 ± 8% of whole-retina levels (±SEM, n =
4). This finding confirms cultured MCs partially dedifferentiate.
We also noted conversion of Glc into Lac and TCA intermediates
by cultured MCs (Fig. 4 A–C), which we would not expect based
on immunocytochemical analysis of intact retinas. Fig. 2 in this
report shows PKM2 is undetectable in MCs within retinas, and
a previous analysis (13) and ours (Fig. S2) detected no AGC1 in
MCs in intact retinas.
Our findings with intact retinas and cultured MCs suggest
a previously unidentified metabolic relationship in which MCs use
Lac and Asp made by PRs. However, cultured MCs only partially
represent authentic MCs, so we developed an independent strategy
to analyze metabolic relationships between PRs and MCs in
intact retinas.
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Fig. 3. Cultured MCs use Asp more effectively than Glc, Lac, and Gln. (A) Ac-
cumulation of M3 lactate and pyruvate from 13C Glc in retinas and in cultured
MCs. Cultured MCs do not make Lac fast enough for Müller glia to be the pri-
mary source of Lac from retinas. CulturedMCs were incubated for 1 h with 5mM
U-13C Lac (B), 5 mM U-13C Glc (C), and 5 mM U-13C Asp (D). The 13C enrichment is
expressed as the percentage of total ion intensity of all isotopomers for each
metabolite (n = 3). 13C Asp is incorporated more effectively than any other fuel.
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Metabolic Fate of 13C-Labeled Gln in Intact Retinas Confirms a Role for
Asp in Neuron/MC Symbiosis.We designed a pulse–chase strategy to
test our hypothesis that Asp transports oxidizing power and car-
bons from neurons to MCs in intact retinas.
PRs are the primary site of Gln catabolism, and MCs are the
primary site of Gln synthesis. Microarray data (26) confirm this
enzyme distribution. Glutaminase (GLS) transcripts occur at an
approximately eightfold higher frequency in PRs than in MCs. In
contrast, transcripts encoding GLUL occur 50-fold more fre-
quently in MCs than in PRs. Based on these distributions and on
the ability of Asp and Lac to enhance Gln synthesis, we hy-
pothesized the pathway in Fig. 5A. Gln is imported into PRs.
GLS converts it to Glu, which is transaminated to α-ketogluta-
rate. A small fraction (7) of this α-ketoglutarate is oxidized to
succinate, to malate, and to oxaloacetate, and is then trans-
aminated to Asp. Our model predicts some of this Asp exits the
neuron to be imported into MCs. Once in the MC cytosol, Asp is
transaminated to oxaloacetate, which then oxidizes cytosolic
NADH. This sequence of reactions is how Asp helps maintain
cytosolic NAD+ to support oxidation of Glc and Lac.
Malate from reduction of oxaloacetate in the MC then
enters mitochondria, where NAD+ oxidizes it to oxaloacetate.
Oxaloacetate is trapped in the MC mitochondria because MCs
lack AGC1, so it is used there to make citrate, which then is ox-
idized to α-ketoglutarate and Glu. Ultimately, in an MC-specific
reaction, the Glu is made into Gln. The net result is that carbons
from Gln initially taken up by PRs are used to resynthesize Gln in
MCs. Fig. 5A tracks the flow of carbons in this model.
To test the strategy, we treated retinas for 5 min with U-13C
Gln (M5), followed by incubation with 5 mM unlabeled Lac. At
various times, retinas were harvested and metabolites were
extracted and analyzed by GC/MS. Fig. 5B (Upper) shows that
M5 Gln converts rapidly to M5 Glu. The lingering M5 Glu and
M5 α-ketoglutarate are consistent with our previously reported
finding that α-ketoglutarate in retinas is protected from ox-
idation in neurons (7). Fig. 5B (Lower) shows how M4 Asp
accumulates and then decays as M3 Glu and then M3 Gln
accumulate. Conversion of M4 Asp into M3 Gln confirms that
the subsequent reactions (Fig. 5A) occur in MCs, because only
MCs express GS. Overall, these results support the model in Fig.
5A in which Asp from neurons supplies carbons and oxidizing
power for synthesis of Gln by MCs.
Confirmation That Asp Can Be a Surrogate for the Missing MAS in
MCs. An alternative interpretation of our results could be that
U-13C Gln is used directly by MCs, where it is made directly into
M3 Gln. This sequence of reactions would not require import of
extracellular Asp into Müller glia. This alternative explanation is
unlikely, because the role of MCs is to synthesize Gln rather than
break it down. Nevertheless, to address this alternative explanation,
we performed the following control experiments that test whether or
not Gln synthesis in MCs depends on import of extracellular Asp:
i) We added (2S, 3S)-3-{3-[4-(trifluoromethyl)benzoylamino]
benzyloxy]aspartate to retinas to inhibit EAAT1, a transporter
for Asp into MCs (31). Fig. 6A shows it inhibits formation of
M3 Gln from M5 Gln without affecting other metabolites.
ii) We treated retinas with carbamoyl-phosphate synthetase 2,
aspartate transcarbamylase, and dihydroorotase, a multien-
zyme complex that converts Asp to N-carbamoyl aspartate
(32), to deplete extracellular Asp. Fig. 6B shows that it inhib-
its M3 Gln formation without affecting other metabolites.
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malate, but only in the absence of Asp (n = 3). The M3 isotopomers of citrate
and malate are made by carboxylation of Pyr. Total citrate and malate in-
creased only ∼70% and ∼7%, respectively, when Asp was included. (D) Asp
(5 mM) increases synthesis and release of Gln into the MC culture medium
(n = 3). (E) Asp stimulates synthesis of Gln from U-13C Lac by MCs in intact
retinas (note log scale on y axis). (F) Asp and Asn are the most effective
anapleurotic substrates for raising the concentration of Gln in retinas. Ret-
inas were incubated with 5 mM lactate and 5 mM additional substrate for
1.5 h (n = 3). The effect on Glu is much smaller. In mouse retinas incubated
with Lac alone, the Glu pool size is ∼130-fold larger than the Gln pool size.
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Fig. 5. Pulse–chase analysis of U-13C Gln in retina. (A) Schematic model for
the role of Asp as a carrier of oxidizing power between retinal neurons and
glia. Red circles represent the 13C carbons, and black circles represent the 12C
carbons. (B) 13C labeling of Asp, Glu, and Gln from the pulse of U-13C Gln.
(Upper) The M5 Gln and Glu are derived directly from the pulse of 5 mM
U-13C Gln. After 5 min, the medium was changed to 5 mM unlabeled Lac
with no added Gln. Unlabeled Gln was not included in the chase because the
intense signal from the added Gln would have obscured the isotopomer
signals we intended to quantify. The retinas were subsequently harvested at
the indicated times after the pulse. (Lower) The M4 Asp derived from oxi-
dation of Glu via the TCA. The M3 Glu is made by further oxidation via
citrate, and M3 Gln is made only in MCs by Gln synthetase. (n = 6).
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iii) We compared Gln in normal retinas and AGC1−/− retinas.
AGC1 is required for Asp synthesized in neurons to es-
cape from the matrix. Our model predicts AGC1 deficiency
should limit synthesis of Gln by MCs by limiting release of
Asp from neurons. Fig. 6C shows that Asp and Gln in
AGC1−/− retinas are diminished compared with controls,
consistent with our model. N-acetyl aspartate also is dimin-
ished in the absence of AGC1, consistent with a previous
analysis of AGC1 deficiency in brain (33).
iv) Our findings suggest AGC1 deficiency limits Gln synthesis by
preventing PRs from exporting Asp for import by MCs. We
tested this explanation by adding exogenous Asp to AGC1−/−
retinas. Fig. 6D shows Asp restores Gln synthesis in AGC1−/−
retinas, consistent with our model.
v) Aminotransferases play key roles in both PRs and MCs. We
incubated retinas under conditions similar to those condi-
tions in Fig. 5, but we also included 1 mM aminooxyacetate
(AOA) to inhibit aminotransferase activities. Fig. 6E shows
AOA lowers Asp and Gln, consistent with our model.
These controls confirmed the importance of Asp as a source of
carbon for Gln synthesis by MCs in intact retinas.
Discussion
Metabolic Requirements in Retina Are Different from in Brain. Met-
abolic relationships between neurons and astrocytes in brain
have been studied extensively (10, 34). However, retina and brain
have different functions and structures that influence the nature
of the interactions between their neurons and glia:
i) Aerobic glycolysis accounts for 2–25% of Glc metabolism in
brain (3), but it accounts for 80–96% of it in retina (4–6).
PKM2 is barely detectable in brain but abundant in retina.
ii) Brain astrocytes have direct access to nutrients and O2 from
vasculature, but some neurons do not. Those neurons rely on
astrocytes for fuel (10, 34). In retina, PRs and MCs have direct
and equal access to nutrients and O2 from the interphotore-
ceptor matrix (IPM) that bathes the retina surface (35).
iii) Neurons in brain fire intermittently, releasing Glu primarily when
they are stimulated. In darkness, PRs are constantly depolarized
such that they release a continuous flow of Glu at their terminals.
iv) Glu released from neuronal synapses in brain can diffuse
from synapses to be recovered by astrocytes. PR synapses
are encapsulated structures with efficient EAAT5 transporters
that recover Glu before it can reach MCs (36). Brain slices,
but not intact retinas, release Gln into the culture medium (7).
Why Do PRs Express So Much PKM2? PKM2 in a mouse retina is 25%
as abundant as rhodopsin, the most prominent protein in PRs. It is
the isoform of PK most suited for aerobic glycolysis in cancer cells
(2, 16) because its activity is poised for either positive or negative
regulation. We have not found evidence that PKM2 is regulated by
light, but there could be conditions we have not yet explored where
its ability to be regulated imparts a selective advantage. PKM2 basal
activity is lower than that of other isoforms (25), but it is so abun-
dant in PRs that retinas convert ∼90% of the Glc they use to Lac.
Why Do MCs Have a PK Deficiency? The advantage to a MC of low
PK expression is that intermediates of glycolysis become avail-
able for anabolic activities. The disadvantage is that MCs be-
come dependent on other cells to fuel their mitochondria.
MCs may not be completely devoid of PK. Previous studies of
MCs treated with protease and mechanically dissociated from
guinea pig retinas showed that they make Lac (37, 38). Those
studies found less Lac release from a complex of MCs and PRs than
from isolated MCs. They inferred a net flow of lactate from MCs to
PRs, but the analysis did not show it directly. The definitive con-
clusion from our studies is that MCs express much less PK than PRs.
Why Is AGC1 in Neurons but Not in Glia? AGC1 in neurons shuttles
Asp out of the matrix to oxidize NADH in the cytoplasm. A key
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Fig. 6. Inhibition of Asp transfer to MCs inhibits Gln synthesis in retina. (A)
Inhibition of EAAT1 by (2S, 3S)-3-{3-[4-(trifluoromethyl)benzoylamino]ben-
zyloxy]aspartate (TFB-TBOA; 10 μM). (B) Depletion of extracellular Asp by
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihy-
droorotase (CAD). The medium contained CAD protein (6 μg/mL) and ATP
(0.1 mM). (C) Asp, N-acetyl aspartate (NAA) and Gln are diminished in AGC1−/−
mouse retinas. (D) Asp boosts Gln levels in AGC1-deficient retinas (n = 4). (E)
AOA, an aminotransferase inhibitor, inhibits formation of Asp and promotes
formation of citrate, consistent with sequestering oxaloacetate in mitochon-
dria so that it is more likely to be made into citrate. By preventing formation of
Asp and by blocking aminotransferase activity in MCs, AOA (1 mM) also causes
accumulation of α-ketoglutarate (αKG) and lowers Gln (n = 3).
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Fig. 7. Model for relationship between PRs and MCs. MCs are PK-deficient,
so glycolytic intermediates can be used for anabolic activities. MCs are AGC1-
deficient, so mitochondrial oxaloacetate in MCs is not diverted away from the
pathway that leads to Gln synthesis. To compensate for these metabolic defi-
ciencies, PRs produce Lac that MCs can oxidize to Pyr to fuel their mitochondria.
PRs also export Asp that MCs can use to oxidize Lac. Nitrogen for the amino
group of Gln comes from Asp, and nitrogen for the amide group of Gln comes
from NH4
+. Mal, malate; OAA, oxaloacetate; OGC, oxoglutarate carrier; Succ,
succinate. Double-membrane compartments within the cells represent mito-
chondria. Green circles represent Glu, and green cylinders represent Glu receptors.
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function of MCs is to synthesize Gln. AGC1-mediated efflux of
Asp from the matrix would divert oxaloacetate away from synthe-
sis of α-ketoglutarate, the precursor for Gln. The advantage to an
MC of low AGC1 is that Asp is not diverted from the path to Gln.
Role of Lac in the Symbiotic Relationship Between PRs and MCs. Our
findings are most consistent with the model in Fig. 7. PRs and MCs
have direct access to the IPM that bathes the surface of the retina
(35). MCs are PK-deficient, so they cannot make much Pyr directly
from Glc. However, like cells in a tumor (39), MCs and PRs express
different amounts of PK. PRs express abundant PKM2, making
them well-equipped to make Lac from Glc. Lac can be released
from PRs via MCT1 (40) and imported into MCs via MCT4 (41).
Role of Asp in the Symbiotic Relationship Between PRs and MCs. For
MCs to oxidize the Lac they import from PRs, they require an
oxidant. MCs are PK-deficient, so they cannot generate the
Pyr that LDH needs to oxidize NADH. MCs also are AGC1-
deficient, so they cannot use MAS activity to oxidize NADH.
Exogenous Asp can provide the needed oxidizing power. As
outlined in Fig. 7, oxaloacetate derived from Asp is a substrate
that cytosolic malate dehydrogenase can use to oxidize NADH to
NAD+. Malate from this reaction can enter MC mitochondria
via oxoglutarate carrier (13) and be oxidized to oxaloacetate.
The absence of AGC1 in MC mitochondria prevents oxaloace-
tate from escaping. Instead, it is directed toward synthesis of
citrate; isocitrate; α-ketoglutarate; and, ultimately, Gln. Our
findings reveal how Lac and Asp can provide a surrogate for the
missing PK and AGC1 activities in MCs. Asp promotes oxidation
of NADH to support Lac consumption. Asp also provides NH2
to convert α-ketoglutarate to Glu (29), and both Asp and Lac
provide carbons to synthesize Gln.
Experimental Procedures
Retina Tissue Culture.Mice were euthanized by cervical dislocation. Retinas
were isolated and cultured as previously described (42). Retina explants were in-
cubated with 5 mMGlc or 5 mM other 13C tracers in a 5% (vol/vol) CO2 incubator
at 37 °C.
Antibodies. PKM1/rabbit (1:1,000, 7067; Cell Signaling), PKM2/rabbit (1:1,000,
4053; Novus Biologicals and Cell Signaling), phospho-PKM2 (Tyr105) (1:1,000,
3827; Cell Signaling), and GAPDH/goat–anti-GAPDH (1:1,000, sc-20357; Santa
Cruz Biotechnology) antibodies were used. CRALBP antibody was obtained
from Jack Saari (University of Washington, Seattle). Anti-AGC1 was obtained
from the laboratory of one of the authors (J.S.) (43). LICOR goat anti-rabbit
800 and LICOR donkey anti-goat 680 were used as secondary antibodies.
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